Showing results (181-190 of 265) with videos related to

Sort By:
Pageof 27
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 3, 2013
Disseminated toxoplasmosis after allogeneic stem cell transplantation in a seronegative recipientM Osthoff, E Chew, A Bajel, et al.
Mycoses|March 31, 2007
Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin AC O Morrissey, M A Slavin, M A O'Reilly, et al.
Internal Medicine Journal|June 4, 2016
Nephrotic syndrome as a complication of chronic graft-versus-host disease after allogeneic haemopoietic stem cell transplantationE Wong, M Lasica, S Z He, et al.
Blood|December 31, 1997
Recombinant soluble interleukin-11 (IL-11) receptor alpha-chain can act as an IL-11 antagonistD J Curtis, D J Hilton, B Roberts, et al.
Soft Matter|January 16, 2018
Control of collagen gel mechanical properties through manipulation of gelation conditions near the sol-gel transitionA J Holder, N Badiei, K Hawkins, et al.
Australian and New Zealand Journal of Medicine|June 5, 1998
Progress in management of acute myeloid leukaemia (AML) in Australia since 1980: a single institution retrospective studyD M Thomas, J F Seymour, J Szer, et al.
Internal Medicine Journal|March 20, 2004
Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantationJ Szer, S Durrant, A P Schwarer, et al.
Annals of Hematology|November 8, 2006
The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphomaD S Ritchie, J F Seymour, A P Grigg, et al.
The Journal of Clinical Endocrinology and Metabolism|July 13, 2006
Pamidronate reduces bone loss after allogeneic stem cell transplantationA P Grigg, P Shuttleworth, J Reynolds, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 2, 2014
Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantationJ Sasadeusz, H M Prince, A Schwarer, et al.
Pageof 27